DIVIS LABORATORIES
Back to Balance Sheet
|
DIVIS LABORATORIES Last 5 Year Deferred Tax Assets / Liabilities History
[Consolidated]
| Mar2025 | Mar2024 | Mar2023 | Mar2022 | Mar2021 | |
|---|---|---|---|---|---|
| Deferred Tax Assets / Liabilities | ₹498 Cr | ₹572 Cr | ₹523 Cr | ₹407 Cr | ₹335 Cr |
What is the latest Deferred Tax Assets / Liabilities ratio of DIVIS LABORATORIES ?
| Year | Deferred Tax Assets / Liabilities |
|---|---|
| Mar2025 | ₹498 Cr |
| Mar2024 | ₹572 Cr |
| Mar2023 | ₹523 Cr |
| Mar2022 | ₹407 Cr |
| Mar2021 | ₹335 Cr |
How is Deferred Tax Assets / Liabilities of DIVIS LABORATORIES Trending?
| Years | Deferred Tax Assets / Liabilities | % Change | |
|---|---|---|---|
| Mar2025 | ₹498 Cr | -12.94 | |
| Mar2024 | ₹572 Cr | 9.37 | |
| Mar2023 | ₹523 Cr | 28.52 | |
| Mar2022 | ₹407 Cr | 21.53 | |
| Mar2021 | ₹335 Cr | - | |
Compare Deferred Tax Assets / Liabilities of peers of DIVIS LABORATORIES
| Peers & Returns | Market Capitalization | 1 Week | 1 Month | 1 Year | ||
| DIVIS LABORATORIES | ₹170,814.7 Cr | -2.3% | 0.9% | 12.9% | Stock Analytics | |
| SUN PHARMACEUTICAL INDUSTRIES | ₹415,037.0 Cr | -1.3% | -3.9% | -5.8% | Stock Analytics | |
| TORRENT PHARMACEUTICALS | ₹133,332.0 Cr | 0.3% | 3.9% | 19.2% | Stock Analytics | |
| CIPLA | ₹116,933.0 Cr | -4.2% | -3.1% | -1.9% | Stock Analytics | |
| DR REDDYS LABORATORIES | ₹99,350.2 Cr | -3.2% | -4.5% | -11.8% | Stock Analytics | |
| MANKIND PHARMA | ₹91,355.8 Cr | -0.7% | 2.8% | -23.5% | Stock Analytics | |
DIVIS LABORATORIES Share Price vs Sensex
| Share Price Returns(%) | 1 Week | 1 Month | 1 Year |
| DIVIS LABORATORIES | -2.3% |
0.9% |
12.9% |
| SENSEX | -1.7% |
-1.4% |
7% |
You may also like the below Video Courses